CEO of Centre for Commercialization of Regenerative Medicine
CCRM serves as a stimulus for commercializing regenerative medicine-based technologies, cell and gene therapies.
AgeX Therapeutics is a pluripotent stem cell-derived progenitor cell lines founded in 2017 by Michael D. West.